Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/21/2007WO2007054623A3 Mammalian hedgehog signaling inhiabitors
12/21/2007WO2007053573A3 Treatment of cancer with sorafenib
12/21/2007WO2007050783A3 Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
12/21/2007WO2007050271A3 5-lipoxygenase modulators
12/21/2007WO2007049050A3 Modulators of gpr40 for the treatment of diabetes
12/21/2007WO2007047327A3 Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
12/21/2007WO2007038860A8 Odcase inhibitors as anti-virals and antibiotics
12/21/2007WO2007033444A3 Antiviral therapy with carbohydrate binding agents
12/21/2007WO2007026224A3 5-ht1b antagonist composition for depression, anxiety and cognition
12/21/2007WO2007022474A3 HUMAN RIBOSOMAL DNA(rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOF
12/21/2007WO2007016361A3 Novel pharmaceutical compounds
12/21/2007WO2007016338A3 Use of chk2 kinase inhibitors for cancer treatment
12/21/2007WO2007012761A8 Novel polysubstituted 1,1-pyridinyl aminocyclopropanamine derivatives, method for preparing same and pharmaceutical compositions containing same
12/21/2007WO2007006790A3 Combination of a dpp-iv inhibitor and a cannabinoid cb1 receptor antagonist
12/21/2007WO2007001225A8 Thiophene-2-carboxamide derivatives as alpha 7 nicotinic receptor modulators.
12/21/2007WO2006113718A3 Compositions for the treatment of neoplasms
12/21/2007WO2006103342A8 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
12/21/2007WO2006099187A3 Benzoyl peroxide compositions and methods of use
12/21/2007WO2006083916A3 Novel adenosine a3 receptor modulators
12/21/2007WO2006050161A3 Therapeutic furopyrimidines and thienopyrimidines
12/21/2007WO2006041838A3 Heparinoid compositions for treatment and prevention of dementia
12/21/2007WO2006036395A3 Inhibitors of akt activity
12/21/2007WO2005116270A3 Influenza virus vaccine composition and method of use
12/21/2007WO2005110455A3 Combination therapy for treating hepatitis virus infection
12/21/2007WO2003082204A3 Sustained-release gel coated compositions
12/21/2007WO2003063903A3 Modulation of t lymphocytes using dp iv inhibitors
12/21/2007CA2836545A1 Pharmaceutical composition
12/21/2007CA2784304A1 Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
12/21/2007CA2691214A1 Therapy using cytokine inhibitors
12/21/2007CA2690878A1 Biodegradable polymer adhesion barriers
12/21/2007CA2689717A1 Non-toxic anti-cancer drug combining ascorbate, magnesium and a naphthoquinone
12/21/2007CA2665940A1 Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses
12/21/2007CA2660648A1 Compositions and methods for treating diseases
12/21/2007CA2660647A1 A suspension comprising benzimidazole carbamate and a polysorbate
12/21/2007CA2659564A1 Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
12/21/2007CA2659549A1 Compositions and methods relating to novel compounds and targets thereof
12/21/2007CA2659512A1 Novel piperazines, pharmaceutical compositions and methods of use thereof
12/21/2007CA2659099A1 Use of cocoa flavanols and procyanidins to improve executive cognitive and cerebral blood flow
12/21/2007CA2657390A1 Use of a p38 kinase inhibitor for treating psychiatric disorders
12/21/2007CA2656672A1 Methods for the formulation and manufacture of artesunic acid for injection
12/21/2007CA2655565A1 Dph2 gene deletion mutant and uses thereof
12/21/2007CA2655557A1 Method for treatment of wound using aganocides
12/21/2007CA2655414A1 Glucan preparations
12/21/2007CA2655355A1 Use of rpn2 gene expression inhibitor
12/21/2007CA2655327A1 Methods and immune modulatory nucleic acid compositions for preventing and treating disease
12/21/2007CA2655323A1 Treating obesity with muscarinic receptor m1 antagonists
12/21/2007CA2655317A1 Ruminant feed supplement containing rice bran to avoid milk fever
12/21/2007CA2655315A1 2-anilino-4-aminoalkyleneaminopyrimidines
12/21/2007CA2655286A1 Therapeutic or prophylactic agent for allergic dermatitis
12/21/2007CA2655282A1 Pharmaceutical use of substituted piperidine carboxamides
12/21/2007CA2655267A1 Pyrazolopyrimidones
12/21/2007CA2655243A1 Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
12/21/2007CA2655203A1 Spirotropane compounds
12/21/2007CA2655146A1 Benzamide derivatives and uses related thereto
12/21/2007CA2655144A1 Antihypertensive therapy method
12/21/2007CA2655131A1 Treating psychological conditions using muscarinic receptor m1 antagonists
12/21/2007CA2655106A1 Substituted gamma lactams as therapeutic agents
12/21/2007CA2655094A1 Use of pharmaceutical compositions comprising cannabigerol for the treatment of depression
12/21/2007CA2655088A1 Protection against and treatment of age related macular degeneration
12/21/2007CA2655085A1 Cgrp receptor antagonists
12/21/2007CA2655081A1 Cholecystokinin-1 (cck1) receptor antagonists in the treatment of gastrointestinal and related disorders
12/21/2007CA2655019A1 Use of a vasopeptidase inhibitor for the treatment of pulmonary arterial hypertension
12/21/2007CA2654987A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007CA2654982A1 Stable laquinimod preparations
12/21/2007CA2654979A1 Pyrrolidine compounds as renin inhibitors
12/21/2007CA2654891A1 Use of 1,7-dimethylxanthine for the manufacture of a non-anxiogenic psychoanaleptic drug for the treatment of a neuropsychiatric disorder
12/21/2007CA2654876A1 1-8-naphthyridine compounds for the treatment of cancer
12/21/2007CA2654842A1 Thienopyrimidines useful as modulators of ion channels
12/21/2007CA2654811A1 Indoline amide derivatives as ep4 receptor ligands
12/21/2007CA2654792A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007CA2654791A1 A method of reducing amyloid-beta peptide levels using a bisdioxopiperazine
12/21/2007CA2654789A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007CA2654722A1 Thiadiazole compounds and methods of use thereof
12/21/2007CA2654719A1 Combination preparations comprising slv308 and a l-dopa
12/21/2007CA2654699A1 Benzamide derivatives and uses related thereto
12/21/2007CA2654644A1 Novel process and intermediates
12/21/2007CA2654557A1 Combination preparations comprising bifeprunox and l-dopa
12/21/2007CA2654530A1 Compounds for the treatment of metabolic disorders
12/21/2007CA2654515A1 Substituted 3-cyanopyridines as protein kinase inhibitors
12/21/2007CA2654498A1 Substituted pyrazolo[1,5-.alpha.]pyridine compounds and their methods of use
12/21/2007CA2654449A1 Compounds for the treatment of periodontal disease
12/21/2007CA2654439A1 Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide
12/21/2007CA2654410A1 Inhibitors of janus kinases
12/21/2007CA2654405A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007CA2654403A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
12/21/2007CA2654334A1 Antitumoral dihydropyran-2-one compounds
12/21/2007CA2654327A1 Pyrrole derivatives with crth2 receptor modulator activity
12/21/2007CA2654250A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007CA2654244A1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
12/21/2007CA2654212A1 New chemical compounds
12/21/2007CA2654211A1 Combination antihypertensive wafer
12/21/2007CA2654202A1 Imidazopyrazines as protein kinase inhibitors
12/21/2007CA2654111A1 Oral pharmaceutical composition of a poorly water-soluble active substance
12/21/2007CA2654105A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/21/2007CA2654098A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007CA2654041A1 Stable aerosol pharmaceutical formulations
12/21/2007CA2653903A1 Ophthalmic compositions for treating ocular hypertension
12/21/2007CA2653782A1 Topical compositions
12/21/2007CA2653777A1 2-anilino-4-(heterocyclic)amino-pyrimidines
12/21/2007CA2653773A1 Cyclic substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
1 ... 3451 3452 3453 3454 3455 3456 3457 3458 3459 3460 3461 3462 3463 3464 3465 3466 3467 3468 3469 3470 3471 ... 7860